Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (ONCSM) — Cash Flow Quality Index

Latest as of September 2024: 3.74x

Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (ONCSM) has a Cash Flow Quality Index of 3.74x as of September 2024. Operating cash flow of TL33.37 Million exceeds net income of TL8.93 Million, indicating high earnings quality where cash backs reported profits. Explore ONCSM cash flow metrics to assess how effectively this company generates cash.

Cash Flow Quality Index

3.74x
Operating CF / Net Income

Operating Cash Flow

TL33.37 Million
TRY

Net Income

TL8.93 Million
TRY

Data as of

Sep 2024
Most recent filing

Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. Cash Flow Quality Index (2020–2021)

Historical Cash Flow Quality Index for Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check how aggressively does Oncosem Onkolojik Sistemler Sanayi ve Ti reinvest cash to assess the company's total reinvestment commitment from operating cash flow.

Annual Cash Flow Quality Index for Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (2020–2021)

Year-by-year earnings quality comparison for Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S.. For live market cap and the full company financial profile, see Oncosem Onkolojik Sistemler Sanayi ve Ti market capitalisation.

Year Quality Index Operating CF (TRY) Net Income YoY Change
2021 0.72x TL51.68 Million TL71.73 Million ▼ -30.3%
2020 1.03x TL19.41 Million TL18.77 Million
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.